Bloomberg Law
Aug. 23, 2021, 4:37 PM

Pfizer-BioNTech Covid Vaccine Wins Landmark U.S. Approval (3)

Riley Griffin
Riley Griffin
Bloomberg News

The Covid-19 vaccine made by Pfizer Inc. and BioNTech SE was granted a full approval by U.S. regulators, a milestone expected to help bolster the immunization drive amid a renewed surge in infections.

The Food and Drug Administration said in a statement on Monday that it had cleared the shot for the prevention of the disease caused by the novel coronavirus in people 16 and older. It will be marketed under the name Comirnaty.

The approval is the first for a Covid vaccine in the U.S., and it arrives at a crucial time, as the country is ensnared in a ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.